Company intelligence / Profile preview

STI Pharma

Newtown, PA, United States

Ownership: Private
Development stage: Other

Overview

STI Pharma develops and markets both generic and proprietary prescription pharmaceutical products, including injectables, liquids, and oral solids, with an active focus on oncology and other therapeutic areas. All commercial products are manufactured at FDA-registered and NDA/ANDA-compliant facilities and are currently marketed and distributed in the United States and its territories[1][3][4].

Therapeutic areas: OncologyOther
Modalities: Small molecule
Industry: Biotech

Partnerships

Various US and international partners for product development and distribution (names not specified)[5]

Beyond the preview

Go deeper on STI Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STI Pharma.

Explore the full profile